Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/refractory Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06355739
What this trial is testing

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Who this might be right for
B Lymphocytic LeukemiaB Lymphoblastic Lymphoma
Zhu Xiaofan 60
Early research (Phase 1)Study completedNCT00357305
What this trial is testing

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Looking for participantsNCT07283822
What this trial is testing

Amping up With PemJAK

Who this might be right for
Non-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+5 more
Seda S. Tolu 53
Testing effectiveness (Phase 2)Study completedNCT00875056
What this trial is testing

Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 56
Testing effectiveness (Phase 2)UnknownNCT05059912
What this trial is testing

CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma

Who this might be right for
Refractory and Relapsed T Cell Lymphoma
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)WithdrawnNCT05867030
What this trial is testing

Parsaclisib in Patients With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Innovent Biologics (Suzhou) Co. Ltd.
Early research (Phase 1)Looking for participantsNCT06732492
What this trial is testing

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Who this might be right for
NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Early research (Phase 1)Ended earlyNCT03601819
What this trial is testing

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralChronic Lymphocytic Leukemia+4 more
University of Michigan Rogel Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT04544592
What this trial is testing

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin Lymphoma
University of Colorado, Denver 45
Very early researchUnknownNCT05979792
What this trial is testing

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Zhao Weili 35
Early research (Phase 1)Study completedNCT02240719
What this trial is testing

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more
University of California, Davis 20
Large-scale testing (Phase 3)Ended earlyNCT02366663
What this trial is testing

BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
City of Hope Medical Center 3
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Testing effectiveness (Phase 2)Looking for participantsNCT06101381
What this trial is testing

CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma

Who this might be right for
Leukemia, Acute LymphoblasticLymphoma, Non-Hodgkin
University of Sao Paulo 81
Testing effectiveness (Phase 2)Looking for participantsNCT07255963
What this trial is testing

Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University 29
Testing effectiveness (Phase 2)Ended earlyNCT02091063
What this trial is testing

ACY-1215 for Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
LymphomaLymphoid Malignancies
Jennifer Amengual 23
Testing effectiveness (Phase 2)WithdrawnNCT04882163
What this trial is testing

Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Celgene
Large-scale testing (Phase 3)Active Not RecruitingNCT04224493
What this trial is testing

Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

Who this might be right for
Relapsed/Refractory Follicular LymphomaFollicular LymphomaRefractory Follicular Lymphoma
Epizyme, Inc. 599
Testing effectiveness (Phase 2)UnknownNCT04723914
What this trial is testing

Dual Target CAR-T Cells in B-cell Lymphoma

Who this might be right for
Lymphoma, B-CellRelapse/RecurrenceRefractory Lymphoma+1 more
YuLi 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05071209
What this trial is testing

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Alveolar RhabdomyosarcomaRecurrent Ewing SarcomaRecurrent Lymphoma+5 more
National Cancer Institute (NCI) 31
Next Page